Cargando…

ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN

The activation of Hageman factor in solid and fluid phase has been analyzed. Activation of highly purified Hageman factor occurred after it interacted with and became bound to a negatively charged surface. Activation was observed in the absence of enzymes that are inhibitable with diisopropylfluorop...

Descripción completa

Detalles Bibliográficos
Autores principales: Cochrane, C. G., Revak, S. D., Wuepper, K. D.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1973
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139466/
https://www.ncbi.nlm.nih.gov/pubmed/4271629
_version_ 1782143802889207808
author Cochrane, C. G.
Revak, S. D.
Wuepper, K. D.
author_facet Cochrane, C. G.
Revak, S. D.
Wuepper, K. D.
author_sort Cochrane, C. G.
collection PubMed
description The activation of Hageman factor in solid and fluid phase has been analyzed. Activation of highly purified Hageman factor occurred after it interacted with and became bound to a negatively charged surface. Activation was observed in the absence of enzymes that are inhibitable with diisopropylfluorophosphate, phenyl methyl sulfonyl fluoride and ε-amino-n-caproic acid. The binding of [(125)I]Hageman factor to the negatively charged surface was markedly inhibited by plasma or purified plasma proteins. Activation of Hageman factor in solution (fluid phase) was obtained with kallikrein, plasmin, and Factor XI (plasma thromboplastin antecedent). Kallikrein was greater than 10 times more active in its ability to activate Hageman factor than plasmin and Factor XI. The data offer a plausible explanation for the finding that highly purified kallikrein promotes clotting of normal plasma. In addition, the combined results of this and previously reported data from this laboratory indicate that the reciprocal activation of Hageman factor by kallikrein in fluid phase is essential for normal rate of activation of the intrinsic-clotting, kinin-forming, and fibrinolytic systems. Activation of Hageman factor was associated with three different structural changes in the molecule: (a) Purified Hageman factor, activated on negatively charged surfaces retained its native mol wt of 80–90,000. Presumably a conformational change accompanied activation. (b) In fluid phase, activation with kallikrein and plasmin did not result in cleavage of large fragments of rabbit Hageman factor, although the activation required hydrolytic capacity of the enzymes. (c) Activation of human Hageman factor with kallikrein or plasmin was associated with cleavage of the molecule to 52,000, 40,000, and 28,000 mol wt fragments. Activation of rabbit Hageman factor with trypsin resulted in cleavage of the molecule into three fragments, each of 30,000 mol wt as noted previously. This major cleavage occurred simultaneously with activation.
format Text
id pubmed-2139466
institution National Center for Biotechnology Information
language English
publishDate 1973
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21394662008-04-17 ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN Cochrane, C. G. Revak, S. D. Wuepper, K. D. J Exp Med Article The activation of Hageman factor in solid and fluid phase has been analyzed. Activation of highly purified Hageman factor occurred after it interacted with and became bound to a negatively charged surface. Activation was observed in the absence of enzymes that are inhibitable with diisopropylfluorophosphate, phenyl methyl sulfonyl fluoride and ε-amino-n-caproic acid. The binding of [(125)I]Hageman factor to the negatively charged surface was markedly inhibited by plasma or purified plasma proteins. Activation of Hageman factor in solution (fluid phase) was obtained with kallikrein, plasmin, and Factor XI (plasma thromboplastin antecedent). Kallikrein was greater than 10 times more active in its ability to activate Hageman factor than plasmin and Factor XI. The data offer a plausible explanation for the finding that highly purified kallikrein promotes clotting of normal plasma. In addition, the combined results of this and previously reported data from this laboratory indicate that the reciprocal activation of Hageman factor by kallikrein in fluid phase is essential for normal rate of activation of the intrinsic-clotting, kinin-forming, and fibrinolytic systems. Activation of Hageman factor was associated with three different structural changes in the molecule: (a) Purified Hageman factor, activated on negatively charged surfaces retained its native mol wt of 80–90,000. Presumably a conformational change accompanied activation. (b) In fluid phase, activation with kallikrein and plasmin did not result in cleavage of large fragments of rabbit Hageman factor, although the activation required hydrolytic capacity of the enzymes. (c) Activation of human Hageman factor with kallikrein or plasmin was associated with cleavage of the molecule to 52,000, 40,000, and 28,000 mol wt fragments. Activation of rabbit Hageman factor with trypsin resulted in cleavage of the molecule into three fragments, each of 30,000 mol wt as noted previously. This major cleavage occurred simultaneously with activation. The Rockefeller University Press 1973-11-30 /pmc/articles/PMC2139466/ /pubmed/4271629 Text en Copyright © 1973 by The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Article
Cochrane, C. G.
Revak, S. D.
Wuepper, K. D.
ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN
title ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN
title_full ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN
title_fullStr ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN
title_full_unstemmed ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN
title_short ACTIVATION OF HAGEMAN FACTOR IN SOLID AND FLUID PHASES : A CRITICAL ROLE OF KALLIKREIN
title_sort activation of hageman factor in solid and fluid phases : a critical role of kallikrein
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139466/
https://www.ncbi.nlm.nih.gov/pubmed/4271629
work_keys_str_mv AT cochranecg activationofhagemanfactorinsolidandfluidphasesacriticalroleofkallikrein
AT revaksd activationofhagemanfactorinsolidandfluidphasesacriticalroleofkallikrein
AT wuepperkd activationofhagemanfactorinsolidandfluidphasesacriticalroleofkallikrein